Metraipolis › archive › dc_94b21fb45edd
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors — Europe PMC PMID:41445795
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41445795
- DOI
- 10.3389/fonc.2025.1620987
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T19:31:11.008Z
- SHA-256 of the archived text
5cd6a7b9fb94042bfe8cbbb33849d1c9af25311eabaf58816297b70c40ec347e- Stable URL of this page
https://metraipolis.com/documento/dc_94b21fb45edd
How to cite
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors — Europe PMC PMID:41445795 — Europe PMC (en), https://europepmc.org/article/MED/41445795 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_94b21fb45edd (Metraipolis archive dc_94b21fb45edd, sha256 5cd6a7b9fb94042bfe8cbbb33849d1c9af25311eabaf58816297b70c40ec347e)
BibTeX
@misc{dc94b21fb45edd,
title = {A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors — Europe PMC PMID:41445795},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41445795},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_94b21fb45edd; sha256 5cd6a7b9fb94042bfe8cbbb33849d1c9af25311eabaf58816297b70c40ec347e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41445795. Agents can read the archived copy with the MCP tool read_document.